Introduction {#dey373s11}
============

Young boys receiving chemo- or radiotherapy to eradicate cancer or as preconditioning treatment for hematopoietic stem cell transplantation face the possibility of being infertile when they reach adulthood due to the gonadotoxicity of the regimens used ([@dey373C11]). It is estimated that almost half of adult male survivors of paediatric cancer will face fertility problems ([@dey373C7]; [@dey373C40]). Sperm banking cannot be offered to prepubertal patients to safeguard their fertility as mature spermatozoa are not present. The only potential fertility preservation strategy currently offered to these patients involves the cryopreservation of immature testis tissue (ITT) containing spermatogonial stem cells (SSCs) ([@dey373C22]). To date, the methods proposed for fertility restoration using cryopreserved ITT remain experimental and primarily involve testis tissue transplantation (TTT), SSC transplantation or *in vitro* culture of single cells or tissue fragments ([@dey373C5]). Among these approaches, TTT has the advantage that it retains SSCs within their niche and ensures germ cell and supporting cell interactions, providing an optimal microenvironment for cell proliferation, maturation and differentiation ([@dey373C6]). However, since TTT carries a potential risk of reintroducing cancerous cells back to the patient and causing malignant relapse ([@dey373C13]), it should only be considered for patients diagnosed with non-systemic cancer and/or non-malignant hematopoietic disorders ([@dey373C22]). For patients for whom the ITT could potentially be contaminated by neoplastic cells, the organotypic culture aiming at *in vitro* maturation might be a good alternative ([@dey373C3]).

Complete spermatogenesis following auto-transplantation of ITT was first demonstrated in mice ([@dey373C10]; [@dey373C30]; [@dey373C33]) and numerous reports on successful xenotransplantation of ITT from other species followed (hamster: [@dey373C30]; rabbit: [@dey373C33]; bovine: [@dey373C21]; rhesus monkey: [@dey373C9]; horse: [@dey373C25]; cat: [@dey373C14]; dog: [@dey373C1]; buffalo: [@dey373C27]). Preservation of the reproductive potential of sperm generated in xenotransplants has been confirmed either by oocyte activation (ectopic; pig and goat: [@dey373C10]), embryo generation by ICSI (ectopic; rhesus monkey: [@dey373C9]) or the birth of live offspring (intratesticular; rabbit: [@dey373C33]).

Prior to a pilot clinical trial and clinical implementation of ITT transplantation, the feasibility of the technique and the optimal conditions for establishing spermatogenesis using ITT transplants, including the transplantation site, need to be investigated in a human-relevant pre-clinical model. Recently, a study from [@dey373C15] reported for the first time the generation of non-human primate (*Macaca fascicularis*) offspring using sperm derived from juvenile monkey testis xenotransplants (ectopic). However, in human, xenotransplantation of ITT containing spermatogonia as the most advanced germ cell type did not result in complete spermatogenesis and production of spermatozoa. The presence of pachytene spermatocytes and spermatid-like cells were reported in human ITT xenotransplants placed into the scrotum of castrated immunodeficient mice ([@dey373C43]; [@dey373C24]), while early spermatocytes were detected in xenotransplants under the dorsal skin ([@dey373C28]). Studies from [@dey373C37],[@dey373C38]) on intratesticular xenotransplantation of human ITT also reported the differentiation of immature germ cells up to the stage of pachytene spermatocytes. We hypothesised that the reason for not achieving full spermatogenesis in human xenotransplants was the relatively short time that human fragments could be maintained in mice. Therefore, we designed a study to conduct intratesticular transplantation using ITT from primates in which testicular tissue matures much faster (in the marmoset, puberty starts around the age of 11 months, but in the human, it starts around the age of 12 years). Similarities between the common marmoset (*Callithrix jacchus*) and the human (including reproductive hormonal activity, germ cell differentiation and proliferation, and the efficiency of spermatogenesis) render the marmoset as the most accepted pre-clinical animal model for human testicular development ([@dey373C32]; [@dey373C18]). Previously, in marmoset, spermatogonia and spermatocytes were observed by [@dey373C30] while pre-meiotic arrest was reported by [@dey373C42] in ITT xenografts under the dorsal skin.

In this study, we compared two potential transplantation sites and report for the first time complete spermatogenesis with generation of spermatozoa in marmoset transplants following intratesticular xenotransplantation of ITT.

Materials and Methods {#dey373s12}
=====================

Ethical approval {#dey373s13}
----------------

All experimental procedures were performed in compliance with the European legislation of animal experimentation, the German Federal Law on the Care and Use of Laboratory Animals (LANUV NRW 84-02.04.2015.A281) and were approved by the Animal Care and Use Committee of the Vrije Universiteit Brussel (16-216-1).

Testis tissue donors {#dey373s14}
--------------------

Two prepubertal co-twin marmosets aged 6 months (*Callithrix jacchus*) were used for this study (Fig. [1](#dey373F2){ref-type="fig"}A). The marmosets were maintained under standardised conditions in the University of Münster primate facility (Münster, Germany). They were kept in families under a 12-h to 12-h light/dark cycle and fed with food pellets (Altromin; Lage, Germany) together with beef or chicken meat and a daily supplement of fresh fruits and vegetables. They had unlimited access to tap water. Housing and exercise conditions were identical for both animals.

![**Marmoset testis tissue donor information**. (**A**) Basic parameters of the testis tissue donors. (**B**) Representative sections of immature marmoset testis tissue prior to xenotransplantation. Histological identification of spermatogonia as the most advanced germ cell type by H/PAS and immunohistochemical confirmation by MAGE-A4.](dey373f01){#dey373F2}

For the surgical removal of the testes, marmosets were anaesthetised by a single intravenous injection of pentobarbital-sodium (Narcoren; Merial-Boehringer, Ingelheim, Germany; 0.1 ml/kg body weight, 10%, solution). Castration was performed through a scrotal incision, and following removal of the testes, the scrotal skin was stitched. The testes were dissected into small fragments (0.8--1 mm^3^) and kept in cold Dulbecco's Modified Eagle Medium (DMEM; Invitrogen GmBH, Karlsruhe, Germany) at 4°C. The fragments were transported to the Vrije Universiteit Brussel (Brussels, Belgium) and stored overnight at the same conditions. The next morning, the fragments were transplanted.

Transplantation {#dey373s15}
---------------

In total, 147 fragments of marmoset ITT were transplanted either ectopically (*n* = 107) or intratesticularly (*n* = 40) into 4-week-old Swiss Nu/Nu mice (*n* = 20) (Charles River Laboratories, Saint-Germain-Nuelles, France). Prior to transplantation, mice were anaesthetised by a single intraperitoneal injection (7.5 μl/kg body weight) of a mixture of medetomidine hydrochloride (0.1 mg/ml) and ketamine hydrochloride (0.75 mg/ml).

For intratesticular transplantation, a mid-abdominal incision was made, and the testis was exteriorised. Following a fine incision in the tunica albuginea, the transplant was placed under the tunica and the incision was closed using non-absorbable suture (U7003, 10-0; Ethicon, Instruvet, Beringen-Paal, Belgium). A single testis tissue fragment from one marmoset was placed in the testicular parenchyma of one testis of the recipient, while a single fragment from the other marmoset was placed in the contralateral testis ([@dey373C37], [@dey373C38]). Ectopic transplantation was performed simultaneously on the same recipient.

For ectopic transplantation, two or three fragments of testis tissue from each marmoset ([@dey373C30]; [@dey373C42]; [@dey373C15]) were placed under the dorsal skin of each recipient mouse using an implant G13 needle (Popper Precision Instruments, NY, USA). Testis tissue fragments from one marmoset were transplanted on one side of the dorsal midline while fragments from the other marmoset were transplanted on the contralateral side. The position of the transplanted tissue was recorded to determine the identity of the donor.

Transplanted mice were randomly allocated into two study groups: one for evaluation after a 4-month post-transplantation period (*n* = 10) and the other one for evaluation after a 9-month post-transplantation period (*n* = 10). Two mice, one from each time point, died before the time of the analysis, and were not included in the study.

After transplantation, mice were housed in the central animal facility of the Vrije Universiteit Brussel (Jette, Belgium) in individually ventilated cages under a controlled environment of 14-h to 10-h light/dark cycle with access to sterilised diet and water.

Transplant recovery {#dey373s16}
-------------------

Mice were sacrificed by cervical dislocation at 4 and 9 months post-transplantation. For the recovery of the ectopic transplants, the back skin of the mouse was removed, and the transplants were dissected from the skin. The marmoset testis tissue was fixed in formalin-based fixative (AFA0060AF59001; VWR International, Leuven, Belgium) and embedded in paraffin. For the recovery of the intratesticular transplants, the mouse testes were collected and placed in pre-warmed (34°C) DMEM/F12 (Life Technologies, Thermo Fischer Scientific, Gent, Belgium). After removing the tunica albuginea, the testes were fixed and embedded in paraffin. To localise the marmoset testis tissue within the mouse testis, the paraffin-embedded samples were sectioned at 5-μm thickness and immunostaining for human/marmoset specific VIMENTIN (mouse monoclonal anti-VIMENTIN; dilution 1:100; M072501; Dako, Heverlee, Belgium) was performed for every 10th section. The sections between the VIMENTIN-positive sections (sections containing marmoset tissue) were kept for further analysis, whilst the sections between the VIMENTIN-negative sections (sections containing only mouse tissue) were discarded.

Histology {#dey373s17}
---------

Dewaxed sections were stained with haematoxylin/periodic acid-Schiff (H/PAS). Following rehydration in a graded alcohol series (100, 90 and 70% alcohol) and washing in distilled water, sections were oxidised in periodic acid solution (VWR International) for 5 min. After another washing step, sections were placed in Schiff reagent (VWR International) for 15 min. Next, testis tissue sections were washed and counterstained with haematoxylin for 3 min.

Immunohistochemistry {#dey373s18}
--------------------

For immunohistochemical staining, dewaxed and rehydrated sections were washed with phosphate-buffered saline (PBS; Life-technologies, Gent, Belgium) and non-specific peroxidase was blocked with 0.3% (v/v) hydrogen peroxide in methanol for 30 min. Antigen retrieval was performed by heating the tissue sections in citrate buffer (0.01 M, pH 6.0) in a water bath (95°C) for 75 min. Following another washing step, non-specific adhesion sites were blocked with 4% normal goat serum (Tebu-bio, Boechout, Belgium) diluted in PBS or with Cas-block (Life Technologies) (only for CREM-1 antibody) for 30 min. Next, primary antibodies against VIMENTIN (marmoset specific), MAGE-A4 (mouse monoclonal anti-melanoma-associated antigen 4; dilution 1:200; gift from Dr Spagnoli; marker for spermatogonia and primary spermatocytes, marmoset specific), BOLL (mouse monoclonal anti-BOLL; dilution 1:400; H00066037-M03; R&D system, Abingdon, UK; marker for spermatocytes (meiotic cells)), CREM-1 (rabbit polyclonal anti-CREM-1; dilution 1:400; sc-440; Santa-Cruz Biotechnology, Heidelberg, Germany; marker for round spermatids (post-meiotic cells)) and ACROSIN (rabbit polyclonal anti-ACROSIN; dilution 1:500; sc-67151; Santa-Cruz; marker for acrosome visualisation in round, elongating and elongated spermatids (post-meiotic cells), marmoset specific), were applied to the sections and incubated in a humidified chamber overnight at 4°C. After washing, sections were incubated with a peroxidase-labelled secondary antibody (Dako Real Envision Detection System; Dako) for 1 h. Staining was visualised with 3,3′-diaminobenzidine (Dako Real™ Envision™ Envision system; Dako) as the chromogen and haematoxylin as the counterstain. Testis tissue sections from adult marmoset were used as positive control and sections where the primary antibody was omitted served as negative control ([Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}).

Transplant survival {#dey373s19}
-------------------

At both time points, the survival of the transplants was evaluated by light microscopic observation of H/PAS stained sections. Transplants were recorded as 'recovered' if they consisted of well-defined seminiferous tubules containing Sertoli cells and/or germ cells and as 'degenerated' if only interstitial cells and fibrosis were observed. Transplants were recorded as 'non-recovered' if transplants were not detectable by VIMENTIN staining (intratesticular) or if transplants were no longer visible under the dorsal skin (ectopic).

Spermatogonial quantity {#dey373s20}
-----------------------

The number of spermatogonia in the testis tissue transplants was evaluated on MAGE-A4 stained sections. MAGE-A4 is a germ cell marker expressed mainly by spermatogonia (strong expression), but also by primary spermatocytes ([@dey373C35]). Therefore, only MAGE-A4 positive cells located at the basement membrane of seminiferous tubules were counted. Analysis was performed on one cross-section from four different depths of each transplant. Only the round intact tubules were included in the evaluation. The results were expressed as the mean number of MAGE-A4 positive cells per round tubule.

Germ cell differentiation and spermatogenic progress {#dey373s21}
----------------------------------------------------

The level of germ cell differentiation in the testis tissue transplants was assessed by morphological identification of different germ cell types on H/PAS stained sections. The presence of spermatogonia and primary spermatocytes was confirmed by immunostaining for MAGE-A4, and meiotic activity was confirmed by staining for BOLL protein. Transplants with elongating or elongated spermatids or spermatozoa were identified as transplants with complete spermatogenesis. The presence of post-meiotic cells was confirmed by immunostaining for the post-meiotic marker CREM-1 ([@dey373C2]). Staining for ACROSIN confirmed the presence of round, elongating and elongated spermatids ([@dey373C19]).

To evaluate the spermatogenic progress in the intratesticular transplants, the percentage of seminiferous tubules with the most advanced germ cell type present was assessed per transplant for both time points. Tubular cross-sections were recorded: as 'no germ cells' if germ cells were lacking; as 'pre-meiotic' if spermatogonia were the most advanced germ cell type; as 'meiotic' if tubules contained spermatocytes as the most advanced germ cell type; and as 'post-meiotic' if spermatids or spermatozoa were observed. All seminiferous tubules in every 10th section were counted for each transplant.

Statistical analysis {#dey373s22}
--------------------

Statistical analysis was performed using GraphPad Prism 6 (La Jolla, CA, USA). The chi-squared test was applied to compare the percentages of transplant survival between different transplantation sites. Statistical differences between subcutaneous transplants and intratesticular transplants were determined using the Mann--Whitney *U* test. Data on the intratesticular transplants between the two time points were analysed by applying paired *t*-test. *P* \< 0.05 was considered significant. Data are expressed as mean ± SD.

Results {#dey373s23}
=======

Transplant survival {#dey373s24}
-------------------

Marmoset testis tissue xenotransplants were recovered at 4 and 9 months post-transplantation (Fig. [2](#dey373F3){ref-type="fig"}). For ectopic transplants, 4 months post-transplantation, 21% (10/48) were recovered, 25% (12/48) were degenerated and 54% (26/48) could not be not recovered. For intratesticular transplants, 50% (9/18) were recovered, 11% (2/18) were degenerated and 39% (7/18) could not be recovered. Overall, the survival rate of the intratesticular transplants was higher compared to the ectopic transplants (*P* = 0.019). Nine months post-transplantation, 20% (10/49) of the ectopic transplants were degenerated and 80% (39/49) could not be recovered. On the contrary, the survival rate was significantly higher (*P* \< 0.0001) for the intratesticular transplants as 50% (9/18) of the transplants were recovered, while 39% (7/18) were degenerated and 11% (2/18) could not be recovered. No difference was detected in the transplant survival between the two donor marmosets at any time point ([Supplementary Table S1](#sup2){ref-type="supplementary-material"}).

![**Recovery of marmoset testis tissue xenotransplants and spermatogonial quantity**. (**A**) Recovery of ectopic marmoset testis xenotransplants in immunodeficient mouse. Transplant contains seminiferous tubules with germ cells as histologically observed by H/PAS. (**B**) Recovery of intratesticular xenotransplants. Localisation of the transplant within the mouse testicular parenchyma by immunostaining for VIMENTIN (brown) and the histology of marmoset testis tissue on the subsequent H/PAS stained section. (**C**) Increased survival rates for the intratesticular marmoset testis tissue xenotransplants compared to the ectopic xenotransplants at 4 (*P* \< 0.05) and 9 months (*P* \< 0.0001) post-transplantation. (**D**) Mean number of spermatogonia per tubule in the xenotransplants. \**P* \< 0.05; \*\**P* \< 0.01.](dey373f02){#dey373F3}

Spermatogonial quantity {#dey373s25}
-----------------------

For each ectopic transplant, 54.1 ± 15.8 well-preserved round seminiferous tubules were analysed (541 tubules in total, 131 for marmoset A and 410 for marmoset B) at 4 months post-transplantation. For each intratesticular transplant, 47.11 ± 15.3 well-preserved round seminiferous tubules were analysed (424 tubules in total, 154 for marmoset A and 270 for marmoset B) at 4 months post-transplantation, and 44.4 ± 18.7 well-preserved round seminiferous tubules were analysed (400 tubules in total,197 for marmoset A and 203 for marmoset B) at 9 months post-transplantation. No difference was observed in the number of spermatogonia per tubule between ectopic and intratesticular transplants at 4 months post-transplantation (6.4 ± 1.6 vs. 7.0 ± 1.0). The number of spermatogonia in the intratesticular transplants was significantly higher at 9 months post-transplantation compared to 4 months post-transplantation (11.7 ± 5.1 vs. 7.0 ± 1.0; *P* = 0.018).

Germ cell differentiation {#dey373s26}
-------------------------

Histological analysis revealed that spermatogonia were the most advanced germ cells in marmoset ITT at the time of transplantation (Fig. [1](#dey373F2){ref-type="fig"}B). Spermatogenesis in all (10/10) recovered ectopic transplants was ongoing but did not progress beyond the spermatocyte stage during the first 4 months post-transplantation (Fig. [3](#dey373F4){ref-type="fig"}). On the contrary, at 4 months post-transplantation, 78% (7/9) of the recovered intratesticular transplants showed post-meiotic differentiation confirmed by the presence of round, elongating and elongated spermatids and 33% (3/9) showed complete spermatogenesis. Complete spermatogenesis and spermatozoa were observed in all recovered (9/9) intratesticular transplants at 9 months post-transplantation (Fig. [4](#dey373F5){ref-type="fig"}).

![**Germ cell differentiation in ectopic marmoset testis tissue xenotransplants at 4 months post-transplantation**. Morphological identification of spermatogonia and spermatocytes by H/PAS and VIMENTIN, and confirmation by immunostaining for MAGE-A4 and BOLL expression. Transplants were negative for the post-meiotic marker CREM-1. Arrows indicate spermatocytes in the lumen of marmoset seminiferous tubules; arrowheads indicate spermatogonia at the basal membrane.](dey373f03){#dey373F4}

![**Germ cell differentiation in intratesticular marmoset testis tissue xenotransplants**. Morphological identification of post-meiotic germ cells by H/PAS, and on VIMENTIN and MAGE-A4 stained sections and immunohistochemical confirmation by CREM-1 expression and acrosome visualisation by immunostaining for ACROSIN. Arrowheads indicate round spermatids; arrows indicate elongating/elongated spermatids.](dey373f04){#dey373F5}

Spermatogenic progress {#dey373s27}
----------------------

For intratesticular transplants, 233.9 ± 113.7 seminiferous tubules were analysed (2105 seminiferous tubules in total, 859 for marmoset A and 1246 for marmoset B) at 4 months post-transplantation, and 283.0 ± 202.3 seminiferous tubules (2547 seminiferous tubules in total,1228 for marmoset A and 1319 for marmoset B) at 9 months post-transplantation. Intratesticular transplants contained a significantly higher percentage of seminiferous tubules with post-meiotic cells at 9 months compared to 4 months post-transplantation (37 vs. 5%; *P* \< 0.001). In addition, there were fewer tubules without germ cells at 9 months compared to 4 months post-transplantation (2 vs. 8% respectively; *P* = 0.014). The percentage of seminiferous tubules with meiotic cells as the most advanced germ cell type was lower at 9 months compared to 4 months post-transplantation (38 vs. 54%; *P* = 0.004), while the percentage of tubules containing pre-meiotic cells was similar (23 vs. 33%; *P* = 0.067) at both time-points (Fig. [5](#dey373F6){ref-type="fig"}).

![**Spermatogenic progress in intratesticular marmoset testis tissue xenotransplants**. Percentages of seminiferous tubules containing no germ cells, pre-meiotic (spermatogonia), meiotic (spermatocytes) and post-meiotic (spermatids and spermatozoa) germ cells in the recovered marmoset transplants at 4 and 9 months post-transplantation. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](dey373f05){#dey373F6}

Discussion {#dey373s28}
==========

To our knowledge, this is the first study to demonstrate the production of spermatozoa following intratesticular transplantation of immature non-human primate testis tissue. Transplantation of marmoset testis fragments into the testicular parenchyma of immunodeficient mice supported the initiation and establishment of complete spermatogenesis and enabled the long-term survival of the transplants. On the contrary, subcutaneous transplantation was inadequately supported over the longer period, with none of the transplants surviving at 9 months post-transplantation. Moreover, only spermatogonia and spermatocytes were observed at 4 months post-transplantation.

The present study has compared ITT survival following ectopic and intratesticular xenotransplantation over an extended period. Previous studies conducting subcutaneous TTT from neonatal and prepubertal marmosets reported the recovery of xenotransplants, containing spermatogonia or spermatocytes as the most advanced germ cell type up to 4 and a half months post-transplantation ([@dey373C30]; [@dey373C42]). The survival of transplants without microvascular anastomosis depends on neovascularisation and establishment of a circulatory connection with the recipient to secure a sufficient oxygen and nutrient supply. Prolonged warm ischemia time is associated with transplant failure ([@dey373C36]) and may depend on the transplantation site, due to differences in vascularisation between sites ([@dey373C12]). The testis is a well vascularised organ, similar to muscle and kidney capsules ([@dey373C34]), which is not the case for the subcutaneous site ([@dey373C39]). Therefore, the testicular parenchyma can provide fast and efficient transplant revascularisation and consequently minimise the period of post-transplantation hypoxia. In a clinical setting, it is possible that normal vascularisation may be disturbed in some patients due to the gonadotoxic treatment but strategies to improve the vascularisation of the transplants using angiogenic factors, such as vascular endothelial growth factor (VEGF) have been reported. A positive effect of VEGF on transplant neovascularisation has been observed in mouse ITT transplants following hydrogel delivery ([@dey373C23]) and in human ITT transplants by *in vitro* pre-treatment of the tissue prior to xenotransplantation ([@dey373C20]). In our study, the combination of a limited vascularisation with the increased metabolic needs and high demand for oxygen of the growing subcutaneous marmoset transplants could have resulted in their gradual degeneration. This hypothesis has also been proposed to explain the failure of adult testis tissue xenotransplantation ([@dey373C4]; [@dey373C29]). Indeed, subcutaneous transplants appeared to be smaller compared to the intratesticular transplants at the same time point. The limited vascularisation and hypoxic conditions might have caused the observed degeneration of tubules and fibrosis in both peripheral and central regions of the transplants. Less fibrosis was observed in the intratesticular transplants. In general, the recovery rate of the transplants, both intratesticular and subcutaneous, appears to be lower than the rates reported in other xenotransplantation studies, although it is difficult to make an accurate comparison due to the different species used, the size of the fragments and the length of the xenotransplantation period. However, it is worth mentioning that in our study, we classified the transplants into three categories: 'recovered', 'degenerated' and 'non-recovered' while the other studies distinguish only between 'recovered' and 'non-recovered' transplants. Therefore, it is possible that the 'degenerated' transplants (transplants that were recovered but contained no well- defined tubules) were also included in the 'recovered' group, resulting in ostensibly higher survival rates. Despite the lower survival rate of the subcutaneous xenotransplants, both transplantation sites supported spermatogonial survival with the number of spermatogonia per tubule being similar between subcutaneous and intratesticular transplants at 4 months post-transplantation, while at 9 months intratesticular transplants contained more spermatogonia which reflects the growth of the transplants and the effective establishment of the spermatogenic process.

Intratesticular xenotransplantation of marmoset ITT enabled the differentiation of spermatogonia into meiotic cells and ultimately spermatozoa. The 9-month transplants showed fewer tubules without germ cells and more tubules containing post-meiotic cells, indicating progressive and sustained spermatogenesis. The proportion of tubules containing pre-meiotic cells remained similar. Tubules containing no germ cells at 4 months were repopulated by spermatogonia, while in the tubules containing meiotic cells at 4 months, germ cells further differentiated into spermatids and spermatozoa.

In other non-human primates, complete spermatogenesis has been reported previously and the sperm obtained from subcutaneous xenotransplants has been used to generate embryos by ICSI up to the blastocyst stage (rhesus monkey; [@dey373C9]) and live offspring (cynomolgus monkey; [@dey373C15]). In the latter study, mature sperm was observed in fresh and frozen--thawed fragments from two juvenile monkeys transplanted subcutaneously in nude mice at 10 months post-transplantation. Acceleration of testicular maturation has been reported by 1--2 years while most of the transplants survived and grew well, with some even up to 17 months post-transplantation, but no data on the actual survival rates were provided. These and most of the other studies were performed using castrated recipients to mimic the hormonal milieu just before puberty with high levels of pituitary gonadotrophins, due to the removal of the negative feedback by testosterone and inhibin. The increased level of FSH in the castrated recipients stimulated Sertoli cell proliferation while LH triggered testosterone production in (primate) ectopic ITT transplants ([@dey373C10], [@dey373C9]). In other studies, additional manipulation of the endocrine environment of the castrated recipient by exogenous administration of gonadotrophins was necessary to achieve spermatogenesis ([@dey373C25], [@dey373C26]). Lack of complete spermatogenesis in ectopic marmoset ITT xenotransplants was initially attributed to their unique LH receptor, resulting in unresponsiveness to mouse LH and arrest of germ cell differentiation ([@dey373C8]). Nonetheless, co-transplantation with hamster testis tissue, for local testosterone support, or with exogenous administration of human chorionic gonadotrophin, failed to establish spermatogenesis ([@dey373C42]). However, autologous transplantation of ITT into the scrotum of immature castrated marmosets led to complete spermatogenesis, with 32% of the seminiferous tubules of the transplants containing post-meiotic germ cell after 14 months, although ectopic transplants showed spermatogenic arrest, confirming the need for a lower temperature environment to induce germ cell differentiation ([@dey373C41]; [@dey373C16]). In this study, we showed that the testicular parenchyma is a superior site for transplanting ITT, likely because of its optimal temperature regulation and the unique hormonal environment essential for germ cell maturation, without the necessity for castration or gonadotrophin stimulation.

Even though intratesticular xenotransplantation of marmoset ITT led to post-meiotic differentiation of germ cells, previous studies utilising ITT from prepubertal boys have not been successful. Transplantation of human ITT into the testicular parenchyma of recipient mice resulted in germ cell differentiation up to the spermatocyte stage at 9 months post-transplantation ([@dey373C37]), despite exogenous FSH administration ([@dey373C38]). Germ cell differentiation and transformation into spermatozoa requires the maturation of the testicular microenvironment, including the Sertoli cells, which are critical for the support of spermatogenesis ([@dey373C31]). Indeed, the previous studies confirmed the functionality of Sertoli cells in the human transplants, but not their fully matured status, as indicated by the expression of anti-Mullerian hormone, a marker for Sertoli cell immaturity, at 9 months post-transplantation. The results of this study are significant for future studies on human ITT xenotransplantation. Initially, it was suggested that species-specific characteristics in the organisation of spermatogenesis was the cause for failure to obtain haploid germ cells following xenotransplantation (e.g. multiple stages of spermatogenesis in one tubule in marmoset and human, while in rodents and rhesus monkey, only one stage of spermatogenesis is found per tubule ([@dey373C17]; [@dey373C41])). However, here, we showed that complete spermatogenesis in marmoset ITT xenotransplants is achievable when transplanted into the testicular parenchyma. These results support our hypothesis that the generation of sperm in human ITT xenotransplants may require a prolonged (more than 9 months) transplantation period. Humans have a long prepubertal period and such xenotransplantation studies could be limited by the short lifespan of the mouse recipient. Future studies focusing on the increase of the xenotransplantation period either by the re-transplantation of the already transplanted testis tissue into a younger recipient or by using other species as recipients, e.g. non-human primates, are necessary to identify the possible cause(s) of failure in the human xenotransplants.

The main limitation of our study is that it has not been possible to test the functionality of the spermatozoa in the transplants due to ethical restrictions, but previous studies have confirmed the fertilisation competence of sperm derived from subcutaneous ITT xenotransplants from non-human primates. ([@dey373C9]; [@dey373C15]). However, the use of sperm produced in xenotransplants of immature human testis tissue is unlikely to be a viable clinical option for fertility restoration due to the risk of zoonoses. To extrapolate our results into a clinical setting, autologous transplantation of cryopreserved ITT into the testis of the infertile patient would enable the testicular extraction of viable spermatozoa and the generation of embryos by ICSI. However, auto-transplantation of ITT cannot be considered for patients suffering from systemic cancers due to the risk of reintroducing the disease. In a future study, a comparison between the transplantation of non-human ITT in the testicular parenchyma and in the scrotum, two potential transplantation sites with the same temperature, will contribute to determine the factors and mechanisms regulating spermatogenesis in ITT transplants. Additionally, since high levels of gonadotropins are often reported in patients who become azoospermic following gonadotoxic treatment, the effect of exogenous administration of FSH or human chorionic gonadotropin on transplant survival and germ cell differentiation should be investigated. Moreover, a study on autologous transplantation of ITT in the testicular parenchyma of non-human primates following gonadotoxic treatment as well as analysing the epigenetic normality of the spermatozoa produced, is warranted.

To conclude, intratesticular xenotransplantation of non-human primate ITT resulted in long-term survival of the transplants and complete differentiation of immature germ cells into spermatozoa. These results encourage the design of new experiments on human xenotransplantation and the further development of intratesticular tissue transplantation as a future clinical strategy for fertility restoration in patients having undergone gonadotoxic treatments.
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